文献速递免疫规划

含22F和33F多糖的单价肺炎球菌结合疫苗在小鼠定植与共感染模型中的免疫原性和保护效力

Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
PubMed 文献 · Vaccine · 2018-08-11

研究在成年和幼年C57BL/6小鼠中评估含22F、33F或6A多糖的单价PCV的免疫原性和保护效力。三种血清型均建立鼻咽定植,流感共感染增加肺炎球菌定植密度;接种诱导血清抗体应答,降低定植密度、预防菌血症并提高22F和6A组生存率。22F疫苗预防流感共感染期间侵袭性肺炎球菌感染的效果与6A疫苗相当。

要点

  • 三种血清型均在小鼠鼻咽建立定植,流感共感染增加肺炎球菌定植密度。
  • 接种单价22F、33F或6A疫苗诱导针对荚膜多糖的血清抗体应答。
  • 接种降低三种血清型定植密度,预防菌血症,22F和6A组生存率提高。

核心结论

  • 单价22F、33F或6A疫苗接种可预防肺炎球菌定植,22F疫苗在流感共感染期间预防侵袭性肺炎球菌感染的效果与6A疫苗相当。

研究设计与样本

  • 成年(六周龄)和幼年(两周龄)C57BL/6小鼠经鼻咽感染22F、33F或6A血清型,定植后一天引入甲型流感H1N1 A/Puerto Rico/8/193病毒(PR8)。
  • 免疫挑战研究中,小鼠接种与CRM197抗原偶联的单价22F、33F或6A多糖疫苗,随后进行定植或共感染以评估疫苗效力。

主要发现

  • 三种肺炎球菌血清型均在成年和幼年小鼠中建立定植,共感染小鼠肺炎球菌鼻咽定植密度增加。
  • 成年小鼠共感染22F和6A血清型后观察到侵袭性肺炎球菌感染(菌血症),33F未观察到;幼年小鼠共感染三种血清型后均发生菌血症。
  • 接种诱导针对荚膜多糖22F、6A的强血清抗体应答,针对33F的应答较弱。
  • 接种降低三种血清型的肺炎球菌鼻咽定植密度,预防菌血症,并使22F和6A血清型感染小鼠生存率提高。
  • 被动转移抗血清与幼年小鼠肺炎球菌定植密度降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the current transmission, we studied the immunogenicity and protective efficacy of serotypes 22F and 33F in the prevention of colonization and of invasive Streptococcus pneumoniae (Spn) pathogenesis during an influenza co-infection. Serotypes 22F and 33F are emerging Spn serotypes, which are not part of currently administered pneumococcal conjugate vaccine formulations (PCVs). Spn serotype 6A is an ingredient in the currently administered PCV13 vaccine and was therefore included in the study as a control. METHODS: Adult (six weeks) and infant (two weeks) C57BL/6 mice were intranasally infected in the nasopharynx (NP) with Spn serotypes 22F, 33F, or 6A. Influenza A H1N1 A/Puerto Rico/8/193 virus (PR8) was introduced one day after the NP Spn colonization. In an immunization challenge study, mice were vaccinated with monovalent 22F, 33F, or 6A polysaccharide conjugated to the CRM197 antigen. The immunized mice were colonized or co-infected to study the vaccines efficacy. RESULTS: All three Spn serotypes established colonization in adult and infant mice. The co-infected mice showed an increase in Spn NP density. Invasive Spn infection (bacteremia) was observed following the co-infection with serotypes 22F and 6A but not 33F in adult mice, whereas infant mice developed bacteremia following co-infection with all three Spn serotypes. The vaccinations led to robust serum antibody responses to capsular polysaccharides 22F, 6A, and less for 33F. The vaccinations resulted in reductions of Spn NP colonization density for all three serotypes, prevention of bacteremia, and increased survival with Spn serotypes 22F and 6A. Passive transfer of antisera was associated with a reduction of Spn colonization densities in infant mice. CONCLUSION: Vaccinations with monovalent 22F, 33F, or 6A formulations protect against Spn colonization, and the efficacy of the 22F vaccination was comparable to the 6A vaccination in preventing an invasive Spn bacterial infection during an influenza co-infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Khan MN, Pryharski K, Pichichero ME, et al. Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection. Vaccine. 2018. PMID: 30107993. doi:10.1016/j.vaccine.2018.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。